PDL BioPharma, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory
PDL BioPharma, Inc. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory of $848.00 thousand as of 2018-01-06, per its 10-Q filed 2018-11-07.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory · last filed 2020-06-29
- 2018-01-06: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $848.00K.
- 2018-01-05: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory $848.00K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory |
|---|---|
| 2018-01-06 | $848.00K 10-Q · filed 2018-11-07 |
| 2018-01-05 | $848.00K 8-K · filed 2020-06-29 |